CHM chimeric therapeutics limited

its not all over!, page-9

  1. 3,997 Posts.
    lightbulb Created with Sketch. 176
    Interesting line in todays ANN by CHM, Chamelean will contend that the accounting for profits must have regard to the capital gain achieved by MMX from the use of the funds.

    They highlight the judges key words 'profit OR benefit'.

    So whilst MMX stated today they had no profit from the project, they did not rule out MMX derived no benefit from the project since purchase.

    Therefore CHM's demand is for 24% of the capital Gains made by MMX since 2004.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $19.57K 4.893M

Buyers (Bids)

No. Vol. Price($)
4 419507 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 18587873 22
View Market Depth
Last trade - 15.59pm 27/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.